Suven Life Sciences inks agreement to buy assets of Rising Pharmaceuticals

08 Mar 2019 Evaluate

Suven Life Sciences has entered into a ‘stalking-horse’ asset purchase agreement to buy the assets of Aceto Corporation’s Rising Pharmaceuticals and rising subsidiaries through its joint venture partner Shore Suven Pharma, Inc., subject to Court-approved bidding process of US Bankruptcy Code.

Shore Suven Pharma, Inc. is a joint venture between Suven Life Sciences and Shore Pharma Investments, LLC of USA.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies using GPCR targets.

Suven Life Sciences Share Price

170.15 -1.25 (-0.73%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×